Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AvePoint (AVPT) Cash & Equivalents (2019 - 2025)

AvePoint (AVPT) has disclosed Cash & Equivalents for 7 consecutive years, with $481.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 65.46% to $481.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $481.1 million, a 65.46% increase, with the full-year FY2025 number at $481.1 million, up 65.46% from a year prior.
  • Cash & Equivalents was $481.1 million for Q4 2025 at AvePoint, up from $471.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $481.1 million in Q4 2025 to a low of $139492.0 in Q1 2021.
  • A 5-year average of $235.6 million and a median of $227.1 million in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: tumbled 81.66% in 2021, then skyrocketed 56364.89% in 2022.
  • AvePoint's Cash & Equivalents stood at $268.2 million in 2021, then fell by 15.3% to $227.2 million in 2022, then dropped by 1.77% to $223.2 million in 2023, then surged by 30.28% to $290.7 million in 2024, then skyrocketed by 65.46% to $481.1 million in 2025.
  • Per Business Quant, the three most recent readings for AVPT's Cash & Equivalents are $481.1 million (Q4 2025), $471.6 million (Q3 2025), and $429.8 million (Q2 2025).